|
Re: Hepalink buys Cytovance Biologics
|
3
|
Resverlogix Corp.
|
Aug 25, 2015 06:07PM
|
|
Corporate Year ends
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 07:01PM
|
|
Re: Wikipedia on Investor Relations: Goal is Fair Valuation
|
3
|
Zenith Epigenetics
|
May 25, 2016 03:51PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
3
|
Zenith Epigenetics
|
Mar 10, 2016 01:45PM
|
|
Re: The problem...as I see it
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 11:22AM
|
|
Immunotherapy for Cancer
|
3
|
Zenith Epigenetics
|
Aug 16, 2019 04:32PM
|
|
Re: What credibility?
|
3
|
Resverlogix Corp.
|
Aug 27, 2017 04:37PM
|
|
Re: Zenith related comments from GAC's Bloom Burton Experience
|
3
|
Zenith Epigenetics
|
May 08, 2018 02:59PM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
3
|
Resverlogix Corp.
|
Jun 06, 2017 03:37PM
|
|
Re: Litter box is full !!!
|
3
|
Zenith Epigenetics
|
Jun 09, 2016 01:15PM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
3
|
Resverlogix Corp.
|
Dec 18, 2017 09:47AM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 21, 2017 02:54PM
|
|
Sleep
|
3
|
Zenith Epigenetics
|
Jan 13, 2022 11:08AM
|
|
Re: Zenith Email this morning
|
3
|
Zenith Epigenetics
|
Aug 18, 2021 01:50PM
|
|
Re: THIS IS NEW ,,, What if
|
3
|
Zenith Epigenetics
|
Jan 18, 2016 04:00PM
|
|
Accelerated approval
|
3
|
Zenith Epigenetics
|
Oct 16, 2019 01:54PM
|
|
Re: 2023 Outlook per MD&A
|
3
|
Resverlogix Corp.
|
Apr 09, 2023 01:24PM
|
|
Re: Consequences of BETonMACE Findings
|
3
|
Resverlogix Corp.
|
May 10, 2016 04:07PM
|
|
Re: Glucose fluctuation
|
3
|
Resverlogix Corp.
|
Jun 15, 2015 02:53PM
|
|
Re: We should get financials this week
|
3
|
Resverlogix Corp.
|
Mar 22, 2021 12:07PM
|
